The British Society for Gene and Cell Therapy at 20 (2003–2023)
Abstract
The year 2023 marks the 20th anniversary of the British Society for Gene and Cell Therapy (BSGCT). In these 20 years, the field of gene and cell therapy has gone from promising strategy to clinical reality. This report describes the history, objectives, organization, and activities of BSGCT to advance research and practice of gene and cell therapy in the United Kingdom.
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCE
1. Seymour LW, Steering Executive Committee of the British Society for Gene Therapy. Trial and error. Lancet 2003;361(9368):1568.
Information & Authors
Information
Published In
Copyright
Copyright 2024, by Mary Ann Liebert, Inc., publishers.
History
Published online: 16 January 2024
Published in print: January 2024
Published ahead of production: 7 December 2023
Accepted: 22 November 2023
Received: 3 November 2023
Topics
Authors
Authors' Contributions
L.S., A.T., A.B., and U.G. contributed to writing—reviewing and editing. R.J.Y.-M. was involved in conceptualization and writing—original draft preparation.
Author Disclosure
All authors have been (L.S., A.T., A.B., and U.G.) or are (R.J.Y.-M.) presidents of BSGCT.
Funding Information
No funding was received for this article.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.